DRD2 activation inhibits choroidal neovascularization in patients with Parkinson's disease and age-related macular degeneration. Mathis, Thibaud; Baudin, Florian; Mariet, Anne-Sophie; Augustin, Sébastien; Bricout, Marion; Przegralek, Lauriane; Roubeix, Christophe; Benzenine, Éric; Blot, Guillaume; Nous, Caroline; Kodjikian, Laurent; Mauget-Faÿsse, Martine; Sahel, José-Alain; Plevin, Robin; Zeitz, Christina; Delarasse, Cécile; Guillonneau, Xavier; Creuzot-Garcher, Catherine; Quantin, Catherine; Hunot, Stéphane; Sennlaub, Florian. The Journal of Clinical Investigation. 2024; 134: p.e174199. doi:10.1172/JCI174199Article